Çocukluk ve ergenlik döneminde büyüme hormonu eksikliği tanı ve tedavisi uzlaşı raporu (Bölüm 1): Büyüme hormonu eksikliği tanısı

Rekombinant büyüme hormonu (BH) 1985 yılından beri kullanımda olmasına karşın büyüme hormonu eksikliğinin tanısı konusunda halen tartışmalı noktalar vardır. Bu nedenle BH eksikliği tanısı konusunda Avrupa'da ve Amerika Birleşik Devletleri'nde birkaç uzlaşı raporu yayınlanmıştır. Bu yazıda çocukluk ve ergenlik dönemindeki büyüme hormonu eksikliğinin tanısı ile ilgili olarak kanıtlara ve uzmanların görüşlerine dayanarak Türkiye'deki Ulusal Pediyatrik Endokrinoloji Derneği'nin önerileri sunulmuştur.

Anahtar Kelimeler:

Büyüme hormonu, Endokrinoloji, Ergen, Çocuk, Eksiklik hastalıkları

Diagnosis and treatment of growth hormone deficiency in childhood and adolescence: Consensus guidelines from the national pediatric endocrinology association in Turkey (Part 1): Diagnosis of growth hormone deficiency

Since recombinant human growth hormone (GH) became available for treatment, the diagnosis of GH deficiency has been subject of many debates and controversies which have resulted in several consensus papers in Europe and USA. This summary statement from the National Pediatric Endocrinology Association in Turkey aims to provide guidelines for diagnosis of GH deficiency in childhood and adolescence based on the evidence from the literature and experience of the treating physicians in Turkey.

Keywords:

Growth Hormone, Endocrinology, Adolescent, Child, Deficiency Diseases,

___

1. Cacciari E, Tassoni P, Cicognani A, et al. Value and limits of pharmacological and physiological tests to diagnose growth hormone (GH) deficiency and predict therapy response: first and second retesting during replacement therapy of patients defined as GH deficient. J Clin Endocrinol Metab 1994; 79:1663-9.
2. Tauber M, Moulin P, Pienkowski C, Jouret B, Rochiccioli P. Growth hormone (GH) retesting and auxological data in 131 GH-deficient patients after completion of treatment. J Clin Endocrinol Metab 1997; 82:352-6.
3. Wyatt DT, Mark D, Slyper A. Survey of growth hormone treatment practices by 251 pediatric endocrinologists. J Clin Endocrinol Metab 1995; 80:3292-7.
4. Guidelines for the use of growth hormone in children with short stature. A report by the Drug and Therapeutics Committee of the Lawson Wilkins Pediatric Endocrine Society. J Pediatr 1995; 127:857-67.
5. American Academy of Pediatrics. Considerations related to the use of recombinant human growth hormone in children. American Academy of Pediatrics Committee on Drugs and Committee on Bioethics. Pediatrics 1997; 99:122-9.
6. Saggese G, Ranke MB, Saenger P, et al. Diagnosis and treatment of growth hormone deficiency in children and adolescents; towards a consensus. Horm Res 1998; 50:320-40.
7. Juul A, Bernasconi S, Chatelain P, et al. Diagnosis of growth hormone (GH) deficiency and the use of GH in children with growth disorders. Horm Res 1999; 51:284-99.
8. GH Research Society. Consesus Guidelines for the diganosis and treatment of growth hormone (GH) deficiency in childhood and adolescence: Summary statement of the GH research society. J Clin Endocrinol Metab 2000; 11:3990-3.
9. Wilson TA, Rose SR, Cohen P, et al. The Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. Update of guidelines for the use of growth hormone in children: the Lawson Wilkins Pediatric Endocrinology Society Drug and Therapeutics Committee. J Pediatr 2003; 143:415-21.
10. Rosenfeld RG. Is growth hormone deficiency a viable diagnosis? J Clin Endocrinol Metab 1997; 82:349-51.
11. Shalet SM, Toogood A, Rahim A, Brennan BM. The diagnosis of growth hormone deficiency in children and adults. Endocr Rev 1998; 19:203-23.
12. Sizonenko PC, Clayton PE, Cohen P, Hintz RL, Tanaka T, Laron Z. Diagnosis and management of growth hormone deficiency in childhood and adolescence. Part 1: diagnosis of growth hormone deficiency. Growth Horm IGF Res 2001; 11:137-65.
13. Tanner JM, Goldstein H, Whitehouse RH. Standards for children's height at ages 2-9 years allowing for height of parents. Arch Dis Child 1970; 45:755-62.
14. Ranke MB. Towards a consensus on the definition of idiopathic short stature. Horm Res 1996; 45:64-6.
15. Gasser T, Molinari L, Roos M. Methodology for the establishment of growth standards. Horm Res 1996; 45:2-7.
16. Cole TJ. Galton's midparent height revisited. Ann Hum Biol 2000; 27:401-5.
17. Luo ZC, Low LC, Karlberg J. A comparison of target height estimated and final height attained between Swedish and Hong Kong Chinese children. Acta Paediatr 1999; 88:248-52.
18. Wright CM, Cheetham TD. The strengths and limitations of parental heights as a predictor of attained height. Arch Dis Child 1999; 81:257-60.
19. Maghnie M, Triulzi F, Larizza D, et al. Hypothalamic-pituitary dwarfism: comparison between MR imaging and CT findings. Pediatr Radiol 1990; 20:229-35.
20. Nagel BH, Palmbach M, Petersen D, Ranke MB. Magnetic resonance images of 91 children with different causes of short stature: pituitary size reflects growth hormone secretion. Eur J Pediatr 1997; 156:758-63.
21. Cianfarani S, Boemi S, Spagnoli A, et al. Is IGF binding protein-3 assessment helpful for the diagnosis of GH deficiency? Clin Endocrinol (Oxf) 1995; 43:43-7.
22. Juul A, Skakkebaek NE. Prediction of the outcome of growth hormone provocative testing in short children by measurement of serum levels of insulin-like growth factor I and insulin-like growth factor binding protein 3. J Pediatr 1997; 130:197-204.
23. Hintz RL. The role of auxologic and growth factor measurements in the diagnosis of growth hormone deficiency. Pediatrics 1998; 102:524-6.
24. Mitchell H, Dattani MT, Nanduri V, Hindmarsh PC, Preece MA, Brook CG. Failure of IGF-I and IGFBP-3 to diagnose growth hormone insufficiency. Arch Dis Child 1999; 80:443-7.
25. Bussieres L, Souberbielle JC, Pinto G, Adan L, Noel M, Brauner R. The use of insulin-like growth factor 1 reference values for the diagnosis of growth hormone deficiency in prepubertal children. Clin Endocrinol (Oxf) 2000; 52:735-9.
26. Juul A. Determination of insulin-like growth factor I in children: normal values and clinical use. Horm Res 2001; 55:94-9.
27. Cianfarani S, Tondinelli T, Spadoni GL, Scire G, Boemi S, Boscherini B. Height velocity and IGF-I assessment in the diagnosis of childhood onset GH insufficiency: do we still need a second GH stimulation test? Clin Endocrinol (Oxf) 2002; 57:161-7.
28. Beck Jensen R, Arp Jeppesen K, Vielwerth S, et al. Insulin-like growth factor I (IGF-I) and IGF-binding protein 3 as diagnostic markers of growth hormone deficiency in infancy. Horm Res 2004; 63:15-21.
29. Juul A, Bernasconi S, Clayton PE, Kiess W, DeMuinck-Keizer Schrama S. Drugs and Therapeutics Committee of the European Society for Paediatric Endocrinology (ESPE). European audit of current practice in diagnosis and treatment of childhood growth hormone deficiency. Horm Res 2002; 58:233-41.
30. Juul A, Holm K, Kastrup KW, et al. Free insulin-like growth factor I serum levels in 1430 healthy children and adults, and its diagnostic value in patients suspected of growth hormone deficiency. J Clin Endocrinol Metab 1997; 82:2497-502.
31. Turan S, Haklar G, Bereket A. Sağlıklı çocuklarda boy, ağırlık, midparental hedef boy, serum IGF-I ve IGFBP-3 düzeyleri ile sosyoekonomik durum arasındaki ilişki. VIII. Ulusal Pediatrik Endokrinoloji Kongresi. 16-21 Aralık 2003, Kongre Kitabı p.140.
32. Badaru A, Wilson DM. Alternatives to growth hormone stimulation testing in children. Trends Endocrinol Metab 2004; 15:252-8.
33. Weinzimer SA, Homan SA, Ferry RJ, Moshang T. Serum IGF-I and IGFBP-3 concentrations do not accurately predict growth hormone deficiency in children with brain tumours. Clin Endocrinol (Oxf) 1999; 51:339-45.
34. Ranke MB, Orskov H, Bristow AF, Seth J, Baumann G. Consensus on how to measure growth hormone in serum. Horm Res 1999; 51:27-9.
35. Andersson AM, Orskov H, Ranke MB, Shalet S, Skakkebaek NE. Interpretation of growth hormone provocative tests: comparison of cut-off values in four European laboratories. Eur J Endocrinol 1995; 132:340-3.
36. Wood P. Growth hormone: its measurement and the need for assay harmonization. Ann Clin Biochem 2001; 38:471-82.
37. Strasburger CJ, Wu Z, Pflaum CD, Dressendorfer RA. Immunofunctional assay of human growth hormone (hGH) in serum: a possible consensus for quantitative hGH measurement. J Clin Endocrinol Metab 1996; 81:2613-20.
38. Strasburger CJ. Methods in determining growth hormone concentrations: an immunofunctional assay. Pediatrics 1999; 104:1024-8.
39. Ghigo E, Bellone J, Aimaretti G, et al. Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children. J Clin Endocrinol Metab 1996; 81:3323-7.
40. Gandrud LM, Wilson DM. Is growth hormone stimulation testing in children still appropriate? Growth Horm IGF Res 2004; 14:185-94.
41. Marin G, Domene HM, Barnes KM, Blackwell BJ, Cassorla FG, Cutler GB Jr. The effects of estrogen priming and puberty on the growth hormone response to standardized treadmill exercise and arginine-insulin in normal girls and boys. J Clin Endocrinol Metab 1994; 79:537-41.
42. Moll GW Jr, Rosenfield RL, Fang VS. Administration of low-dose estrogen rapidly and directly stimulates growth hormone production. Am J Dis Child 1986; 140:124-7.
43. Gonc EN, Yordam N, Kandemir N, Alikasifoglu A. Comparison of stimulated growth hormone levels in primed versus unprimed provocative tests. Effect of various testosterone doses on growth hormone levels. Horm Res 2001; 56:32-7.
44. Simic-Schleicher G. Comparison of stimulated growth hormone levels in primed versus unprimed provocative tests: effect of various testosterone doses on growth hormone levels. Horm Res 2002; 58:187.
45. Ogilvy-Stuart AL. Growth hormone deficiency (GHD) from birth to 2 years of age: diagnostic specifics of GHD during the early phase of life. Horm Res 2003; 60:2-9.
46. Miller JD, Esparza A, Wright NM, et al. Spontaneous growth hormone release in term infants: changes during the first four days of life. J Clin Endocrinol Metab 1993; 76:1058-62.